Sonn stock forecast using Fibonacci retracement levels

SONN stock forecast using Fibonacci retracement levels indicates key resistance near $0. Sonnet BioTherapeutics Holdings (SONN) Stock Forecast & Price ... Current Sonnet shareholders will receive Contingent Value Rights (CVRs) tied to the company's existing biotech assets, which will continue operating as a subsidiary. The biotech division will maintain development of SON-1010 while "disposing of other assets" – language that suggests significant restructuring. Latest SONN stock forecast data shows correlation with NASDAQ biotech index performance, currently trending upward. Support levels are well-defined, but breakout potential requires confirmation above $0.